Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Blood

• Publication date

  2003-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2003-04-1199PMID 12881304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regional mapping of clotting factors VII and X to 13q34. Expression of factor VII through chromosome 8

  2004cited by this paper
• A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide

  2004cited by this paper
• Phenotyping the Clotting System

  2002cited by this paper
• The prothrombin 20210A allele influences clinical manifestations of hemophilia A in patients with intron 22 inversion and without inhibitors.

  2002cited by this paper
• FACTOR VII DEFICIENCY

  2002cited by this paper
• Mild bleeding diathesis in a boy with combined severe haemophilia B (C10400→T) and heterozygous factor V Leiden

  2001cited by this paper
• Symptomatic Onset of Severe Hemophilia A in Childhood is Dependent on the Presence of Prothrombotic Risk Factors

  2001cited by this paper
• Factor X Levels, Polymorphisms in the Promoter Region of Factor X, and the Risk of Venous Thrombosis

  2001cited by this paper
• Factor VII deficiency and the FVII mutation database

  2001cited by this paper
• Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studies.

  2000cited by this paper
• Recombinant Factor VIIa for the Treatment of Congenital Factor VII Deficiency

  2000cited by this paper
• An Assay to Quantify the Two Plasma Isoforms of Factor V

  2000cited by this paper
• Effect of the Factor V Leiden Mutation on the Clinical Expression of Severe Hemophilia A

  2000cited by this paper
• Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.

  1999cited by this paper
• Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration.

  1999cited by this paper
• "Normal" thrombin generation.

  1999cited by this paper
• Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene.

  1998cited by this paper
• An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN).

  1997cited by this paper
• Association of severe haemophilia A and factor V Leiden: report of three cases

  1996cited by this paper
• Factor V Enhances the Cofactor Function of Protein S in the APC-Mediated Inactivation of Factor VIII: Influence of the Factor VR506Q Mutation

  1996cited by this paper
• Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma.

  1996cited by this paper
• A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

  1996cited by this paper
• Moderation of hemophilia A phenotype by the factor V R506Q mutation.

  1996cited by this paper
• Detection of New Polymorphic Markers in the Factor V Gene: Association with Factor V Levels in Plasma

  1996cited by this paper
• Low Prevalence of the Factor V Leiden Mutation Among “Severe” Hemophiliacs with a “Milder” Bleeding Diathesis

  1995cited by this paper
• The Tissue Factor Pathway: How It Has Become a “Prima Ballerina”

  1995cited by this paper
• Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C (*)

  1995cited by this paper
• Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa.

  1994cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper
• Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.

  1994cited by this paper
• Characterization of two forms of human factor Va with different cofactor activities.

  1993cited by this paper
• Continuous Registration of Thrombin Generation in Plasma, Its Use for the Determination of the Thrombin Potential

  1993cited by this paper
• Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region

  1993cited by this paper
• Regulation of blood coagulation by the protein C system

  1992cited by this paper
• The Extrinsic Pathway Inhibitor: A Regulator of Tissue Factor-Dependent Blood Coagulation

  1991cited by this paper
• Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces.

  1991cited by this paper
• A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals.

  1991cited by this paper
• The human factor VII gene is polymorphic due to variation in repeat copy number in a minisatellite.

  1988cited by this paper
• Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation.

  1987cited by this paper
• Structural genes of coagulation factors VII and X located on 13q34.

  1986cited by this paper
• A Computer Assisted Method to Obtain the Prothrombin Activation Velocity in Whole Plasma Independent of Thrombin Decay Processes

  1986cited by this paper
• Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis.

  1985cited by this paper
• Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

  1977cited by this paper

• Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency

  2024cites this paper
• Modulation of Haemostatic Balance in Combined von Willebrand Disease and Antithrombin Deficiency: A Comprehensive Family Study

  2024cites this paper
• The identification of a novel compound heterozygous mutation in hereditary human coagulation factor VII deficiency following a bamboo leaf green snake bite.

  2024cites this paper
• Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease

  2022cites this paper
• Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis

  2021cites this paper
• Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021.

  2021cites this paper
• Diagnosis and Management of FVII Deficiency

  2020cites this paper
• Pediatric Bleeding Disorders: A Clinical Casebook

  2020cites this paper
• Update on Molecular Testing in von Willebrand Disease

  2019cites this paper
• Paradigm shift for the treatment of hereditary haemophilia: Towards precision medicine.

  2019cites this paper
• Modifiers of clinical phenotype in severe congenital hemophilia.

  2017cites this paper
• F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency

  2017cites this paper
• Inheritance of Factor VII and Protein S Deficiency Together with Factor V Leiden Mutation

  2016cites this paper
• EL EQUILIBRIO HEMOSTÁTICO, UN PROCESO COMPLEJO

  2016cites this paper
• Inheritance of Factor VII and Protein S Deficiency Together with Factor V Leiden Mutation Faktör VII ve Protein S Eksikliğinin Faktör V Leiden Mutasyonu ile Birlikte Kalitimi

  2016cites this paper
• Influence of Blood Lipids on Global Coagulation Test Results

  2014cites this paper
• Poor prognosis of hypocoagulability assessed by thrombin generation assay in disseminated intravascular coagulation

  2014cites this paper
• Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency

  2014cites this paper
• congenital factor V deficiency Low plasma levels of tissue factor pathway inhibitor in patients with

  2013cites this paper
• Anticoagulation duration in heterozygous factor V Leiden: a decision analysis.

  2013cites this paper
• Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults.

  2013cites this paper
• GENOME SEQUENCING AND ITS IMPACT ON HEMATOLOGY Genetic sequence analysis of inherited bleeding diseases

  2013cites this paper
• Evaluation of bleeding symptoms of the patients with factor VII deficiency and its association with factor VII activity

  2013cites this paper
• Genetic sequence analysis of inherited bleeding diseases.

  2013cites this paper
• Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: hypercoagulability in patients with vascular access thrombosis.

  2013cites this paper
• Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous?

  2012cites this paper
• Combined congenital dysfibrinogenemia and factor VII deficiency from mutations in the FGB and F7 genes

  2012cites this paper
• Modulators of bleeding tendency in severe factor V deficiency

  2011cites this paper
• Factor XI deficiency : a study of clinical, laboratory and molecular modifiers of bleeding phenotype

  2011cites this paper
• Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system

  2011cites this paper
• Factor deficiencies in pregnancy.

  2011cites this paper
• Modulation of severity of clinical bleeding by co-inherited thrombophilia is also true for severe factor X deficiency.

  2010cites this paper
• Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders

  2010cites this paper
• Congenital Factor VII Deficiency

  2010cites this paper
• Advances in understanding the bleeding diathesis in factor V deficiency

  2009cites this paper
• Factor VII Deficiency

  2009cites this paper
• Multiple gene interaction and modulation of hemostatic balance

  2009cites this paper
• Understanding hemostasis and thrombosis : The lesson learnt from natural models

  2008cites this paper
• Endothelial-coagulative activation during chronic obstructive pulmonary disease exacerbations

  2008cites this paper
• The paradoxical association between inherited factor VII deficiency and venous thrombosis

  2008cites this paper
• Variability of clinical manifestation of factor VII-deficiency in homozygous and heterozygous subjects of the European F7 gene mutation A294V

  2008cites this paper
• U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency.

  2008cites this paper
• Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.

  2008cites this paper
• The hemostatic balance revisited through the lessons of mankind evolution

  2008cites this paper
• U 1-snRNA – mediated rescue of mRNA processing in severe factor VII deficiency

  2008cites this paper
• Coagulation factors and the protein C system as determinants of thrombin generation in a normal population

  2007cites this paper
• Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients

  2007cites this paper
• Influence of Factor V HR2 on Endogenous Thrombin Potential and Clinical Phenotype in Factor VII Deficiency

  2007cites this paper
• The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes

  2007cites this paper
• Influence of Factor V HR2 on Thrombin Generation and Clinical Manifestation in Rare Bleeding Disorders

  2006cites this paper
• Potential predictors of bleeding risk in inherited factorVII deficiency

  2005cites this paper
• Does activated protein C‐resistant factor V contribute to thrombin generation in hemophilic plasma?

  2005cites this paper
• Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.

  2004cites this paper
• How to evaluate phenotype–genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency

  2004cites this paper